Learn more

BEVEC DORIAN

Overview
  • Total Patents
    112
  • GoodIP Patent Rank
    239,631
  • Filing trend
    ⇩ 100.0%
About

BEVEC DORIAN has a total of 112 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, foods and drinks and environmental technology are MONDOBIOTECH LAB AG, BACHER GERALD and MARUHACHI MURAMATSU KK.

Patent filings in countries

World map showing BEVEC DORIANs patent filings in countries
# Country Total Patents
#1 United States 105
#2 WIPO (World Intellectual Property Organization) 3
#3 EPO (European Patent Office) 2
#4 China 1
#5 Germany 1

Patent filings per year

Chart showing BEVEC DORIANs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Bevec Dorian 109
#2 Bacher Gerald 55
#3 Cavalli Vera 54
#4 Cavalli Fabio 54
#5 Mikut Ralf 3
#6 Hilpert Kai 3
#7 Ruden Serge 3
#8 Ziesche Rolf 2
#9 Keri Gyorgy 1
#10 Stroher Ute 1

Latest patents

Publication Filing date Title
WO2018189566A1 Use of a chemical compound as a therapeutic agent
WO2013053772A1 Antimicrobial peptides for treatment of infectious diseases
US2010184679A1 Use of a combination of cart peptides as a therapeutic agent
US2010210534A1 Use of a peptide as a therapeutic agent
US2010210555A1 Use of a laminin peptide as a therapeutic agent
US2010210533A1 Use of urocortin and corticotropin-releasing factor as therapeutic agents
US2010216722A1 Use of the peptide pro-gly-thr-cys-glu-ile-cys-ala-tyr-ala-ala-cys-thr-gly-cys as a therapeutic agent
US2011065630A1 Use of a octreotide as a therapeutic agent
DE102005025906A1 Use of a guanylhydrazone compound in the manufacture of medicament for the treatment and/or prevention of e.g. acute and chronic hepatitis, liver cirrhosis, liver cell carcinoma, myocarditis, pharyngitis, pneumonia and pericarditis